Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KORU vs MRNA✓SelectedUSD · MRNAKORU vs MRNA performance historyLatest closeAs of-25.04%11/20
Stock and ETF performance explorer

KORU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-61.1%
MRNA return
-27.3%
Excess return
-33.8%
Maximum drawdown
-92.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-25.0%-2.2%-22.9%-24.6%
7D-38.0%-12.7%-25.3%-36.3%
30D-60.1%-20.7%-39.5%-57.9%
3M-76.6%+46.3%-122.9%-78.0%
6M-87.5%+305.2%-392.7%-92.3%
YTD-47.6%+561.2%-608.8%-72.2%
1Y-27.8%+772.1%-799.9%-65.2%
3Y+22.5%+147.0%-124.4%-20.1%
All-61.1%-27.3%-33.8%-73.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling